A 12 year old boy with eczema, asthma, and severe intolerance to cows' milk protein ate a small amount of food which contained casein. He developed a severe anaphylactic reaction, and within minutes he was dead.' After recent publicity of similar cases in the press, this is a scenario now greatly feared by parents of children with food intolerance. This article addresses two controversial issues, the immediate treatment of anaphylactic reactions, and the role of adrenaline for home use. The terms anaphylaxis or anaphylactic shock are used in this context to mean a severe reaction of rapid onset, with circulatory collapse and hypotension. Some have used the term anaphylaxis to describe any immediate allergic reaction mediated by IgE antibodies, however mild, but such usage fails to distinguish between a trivial event (for example, a skin test reaction) and a life threatening one. Others use the terms local anaphylaxis and systemic anaphylaxis to describe respectively local reactions (for example, acute angioedema) and generalised reactions; we confine the term anaphylaxis to the latter.
Features of anaphylactic reactions to food Although delayed (12 hours It is unclear why some foods should be more likely than others to provoke anaphylaxis. In some cases anaphylaxis only occurs when a food is taken in conjunction with exercise. There are no studies which have prospectively studied the quantity of food required to provoke anaphylaxis, but anecdotal reports indicate that small quantities may be sufficient. In some cases, food allergens are denatured by cooking, but others are resistant to heat denaturation. It is recognised that occasionally specific food avoidance in a child with relatively mild symptoms of food intolerance is followed by anaphylactic shock when the food is reintroduced. The best known example is cows' milk protein intolerance in infancy, where it is well established that there is a clear risk of anaphylaxis during a milk challenge performed after a period of cows' milk protein avoidance. " I It is for this reason that such milk challenges are often performed in hospital. It has been suggested that enhanced sensitivity is a small risk of food avoidance in a case of food intolerance,'2 and this may apply particularly to children with atopic eczema who are treated with elemental diets.2 8 It is unknown why in some children reactions to a food become progressively more severe with each exposure, whereas in others (even those with very severe reactions13) the reaction does not increase in intensity or even decreases with time.
Treatment of food provoked anaphylactic shock In order of importance, the treatment is as follows.
( Current practice differs widely. Some employ adrenaline selectively, whereas others provide it where the reaction has been very mild (for example, sneezing without other symptoms). We are aware of immunology laboratories which are routinely advising the use of adrenaline syringes for any child who is found to have food specific IgE antibodies (for example, positive RAST test to peanut), regardless of the history. Many doctors are providing preloaded adrenaline syringes without training the parents in their use, which makes no sense. Our own practice is to issue adrenaline to parents only if the child has had a life threatening episode of anaphylaxis. In this context we take life threatening to mean an explosive onset of severe upper airway obstruction, severe bronchospasm and/or shock. Training of the parents, and anyone else likely to be caring for the child, is essential. Our reluctance to supply adrenaline is based on the lack of proof of lifesaving efficacy, and a number of notable drawbacks and risks. The key points are:
(1) Preloaded adrenaline syringes are potentially invasive and restrictive, the child being unable to go anywhere to play without taking the syringe and the parents ensuring that there is a fully trained adult at hand who can both judge the need for injection and have the courage to plunge a needle into someone else's child. The need to avoid certain foods is, of course, also restrictive.
(2) While some parents will be reassured by having adrenaline available, for many the possession of such equipment is associated with enhanced rather than reduced anxiety. For some, fear of the possibility of having to give an injection may be greater than fear of anaphylaxis itself.
(3) Having a preloaded syringe is plainly regarded by some (but not all) parents as a substitute for care in food avoidance, possibly increasing the overall danger to the child.
(4) There is no proof that adrenaline is life saving. The use of adrenaline does not guarantee that hypotension will be corrected, and anaphylactic shock (in some cases fatal) may be refractory to adrenaline.26 27 It appears that many deaths from anaphylaxis happen so rapidly that an injection of adrenaline is unlikely to be life saving. There are many reports of death occurring despite the use of adrenaline. On the other hand, for treatment with adrenaline to stand any chance of benefit, it must be given early, probably at the first sign of an allergic reaction, and adrenaline is the single most useful drug. The latter argument is our justification for supplying adrenaline for home use. The need to give the drug at the first sign of a reaction rather than waiting for life to be visibly in danger is the reason for restricting treatment to those with a previous history of a life threatening reaction. The alternative, of supplying adrenaline to those without a history of severe reaction, risks needless injections (for example, giving the child an adrenaline injection whenever he or she sneezes a few times, just in case a trigger food has been taken), along with a number of other drawbacks listed here.
(5) There is a theoretical hazard of inadvertent intravenous injection, with the risk of arrythmia28-30 and death.
(6) The need to eject surplus adrenaline before administration means that there is an inherent risk of overdosage, with the risk of arrythmia28-30 and death.
(7) The use of adrenaline (for example, searching for syringe) may delay obtaining lifesaving medical treatment. (8) Where the life threatening reaction comprises severe bronchoconstriction, then adrenaline is less effective3l and more toxic than the use of selective ,2-agonists (for example, nebulised salbutamol or terbutaline).
(9) Supply of preloaded syringes with adrenaline has been associated with exclusion from school in some cases. Many schools have reacted favourably and positively, especially when approached sensitively. However, some teachers have argued that it should not be their responsibility to administer injections of adrenaline, or to make the decision as to when such an injection is clinically indicated. Helpfully, some education authorities have provided indemnity for teachers in this position. Nevertheless, a few schools have taken the line that if the threat to life is so great then they are not prepared to take the responsibility for the child and exclusion has resulted. Once an entrenched position has been reached, trying to persuade schools to change their mind can be difficult, and it is vital when considering the supply of adrenaline for home use that there should be prior liaison with the community paediatric service and the school. The risk of exclusion from school has become quite widely known, with bizarre results. We have encountered cases in which the parents requested home adrenaline for the treatment of mild allergic reactions with the specific intention of having the child excluded from school. The parents were members of 'Education Otherwise', an organisation to support families who wish to practise home based education as an alternative to schooling, and further cases of this type can be expected.
A history of a previous anaphylactic reaction to a food is the most important predictor of a subsequent anaphylactic reaction. In the largest series of anaphylactic reactions to foods in children and adolescence, there were six fatal and seven near fatal cases; in all 13, there was a previous history of a serious anaphylactic reaction to food.32 Despite these data, a counter argument to the selective use of home adrenaline syringes is that potentially fatal reactions cannot be predicted on the basis of previous history. The argument of the 'adrenaline missionaries' is that there are very rare cases in which a fatal reaction occurs in whom previous exposure was associated with either mild symptoms or none at all. Thus a child might experience mild urticaria after eating egg, only to die of anaphylaxis the next time egg is consumed. Such cases, although atypical and rare, plainly can occur, and no doctor can guarantee otherwise. If one follows this argument to its logical conclusion, then all children who have experienced an adverse reaction to a food are at risk of death upon re-exposure to that food, and all should carry preloaded adrenaline syringes. Given the high incidence of food intolerance in childhood' this would result in very large numbers of children being equipped with adrenaline syringes. Our own recommendations represent an attempt to balance the relative risks of, on the one hand, a previous history of a life threatening reaction or a mild reaction, against on the other hand the various advantages and disadvantages of adrenaline syringes.
Home administration of adrenalinepractical aspects In Britain there are currently two forms of adrenaline prefilled syringes. The first type is manufactured by International Medical Systems in Daventry, Northamptonshire and distributed by P and D Pharmaceuticals Ltd in Bordan, Hampshire. This contains adrenaline at a concentration of 1 in 1000 (1 mg in 1 ml) and sodium metabisulphite as an antioxidant. The Min-I-Jet adrenaline 1 in 1000 is available as a 1 ml disposable syringe with a 25 gauge short 0-25 inch (6-4 mm) needle for subcutaneous use. The syringe is graduated, starting at 0-2 ml (0-2 mg). In theory increments of 100 ,ug above this can be given, but in practice it is not easy to be very accurate. At a dose of 10 pug/kg, the syringe could not be used for children who weigh less than 20 kg. Since a full syringe delivers 1 mg, the parent or supervising adult has to measure the dose needed by first removing the unwanted contents, leaving the required dose for that patient. This highlights the need for a smaller syringe for children (a 0 5 ml Min-I-Jet is currently being formulated, which would allow it to be administered to a 10 kg child). Due to the unstable nature of adrenaline, the Min-IJet has a shelf life of nine months at 25°C (room temperature). At the time of writing, the cost of each Min-I-Jet syringe is £6.39.
The second type of prefilled syringe is the Epipen autoinjector manufactured by Allerayde in the USA. This does not have a UK product licence and is only available from Allerayde in Newark, Nottinghamshire on a named patient basis. It is designed to deliver 0 3 ml of a 1 in 1000 adrenaline injection (0 3 mg dose) subcutaneously using a spring activated concealed 0-6 inch (15 mm) needle when the pen is pushed firmly against the outer thigh. A paediatric version (Epipen Jr) contains 0-3 ml of a 1 in 2000 adrenaline injection (0-15 mg dose) to be given using a 0 If adrenaline syringes are prescribed, it is essential that parents and other carers are fully trained in their use, and this includes knowing both how and when to inject. It is irresponsible to prescribe such equipment without full instruction. Expired syringes should be kept in such a way that they could not be used in an emergency; they are useful for training purposes. It is important to emphasise that even after adrenaline is administered, medical assistance should be sought urgently, because the effects may wear off quickly and because other lifesaving treatment (for example, intravenous fluids, intubation, artificial ventilation) is likely to be required. It is reasonable for parents to have available a short acting non-sedating antihistamine (for example, terfenadine: the dose, to be given twice a day, is: <3 years (not licensed) 1 mg/kg, 3-6 years 15 mg, 7-12 years 30 mg, >12 years 60 mg).
Adrenaline inhalers
Adrenaline acid tartrate 280 VLg/puff (adrenaline base 154 rig/puff) is available as a metered dose aerosol (Medihaler-Epi). About 1 0% of the drug reaches the lungs and is absorbed, the remainder being exhaled or deposited in the mouth and pharynx and swallowed.33 The aerosol can be fitted into the Volumatic spacer device. In healthy individuals, large doses (15 to 30 puffs) have to be given to achieve the same plasma levels as a 300,ug subcutaneous injection33 34 and the recommended dose for children is 10 to 15 puffs. The patient must be able and know how to use an inhaler.
In theory, the advantages of adrenaline aerosol over subcutaneous injection35 are: (a) quick absorption into the circulation and (b) possible direct effect on mucosal oedema. The disadvantages33 36 are: (a) more reliable, rapid, and prolonged rise of plasma adrenaline after subcutaneous injection; (b) absorption of adrenaline in the lungs may be impaired in patients with laryngeal oedema, bronchoconstriction, or bronchial mucosal oedema; and (c) studies of absorption after inhalation were performed in normal subjects who were able to perform the correct inhalation technique. It is unlikely that acutely ill children with respiratory distress could obtain as good results. Inhaled adrenaline is not generally recommended as an alternative to injected adrenaline.37 38 One suggestion has been that an adrenaline inhaler may be a useful option where a school is unwilling to handle an adrenaline syringe.
Conclusions
Where a child has experienced an anaphylactic reaction to a food appropriate advice should be given to avoid the food. 
